Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:48 AM
Ignite Modification Date:
2025-12-25 @ 2:48 AM
NCT ID:
NCT00239733
Eligibility Criteria:
Inclusion Criteria for All Participants:
* HCV-infected
* Currently on treatment for HCV OR plan to begin treatment for HCV at the start of this study
* Platelet count less than 50,000 cells/microl
* Hemoglobin greater than 10 g/dl OR greater than 11 g/dl if peginterferon treatment-naive
* Red blood cells are Rh (D) antigen-positive
* Negative Coombs direct antibody test
Inclusion Criteria for HIV Infected Group:
* HIV-infected
Inclusion Criteria for HIV Uninfected Group:
* HIV-uninfected
Exclusion Criteria:
* Prior treatment with intravenous immunoglobulin (IVIG), anti-D, or other medication for the treatment of thrombocytopenia within 30 days of study entry
* Prior serious reaction to plasma products
* Absence of spleen
* Evidence of thrombotic thrombocytopenic purpura (TTP) OR cause of thrombocytopenia other than HCV infection, HCV treatment, or HIV infection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00239733
Study Brief:
Protocol Section:
NCT00239733